Abstract
The usual physiological perspective on appetite and food intake regards control of eating simplistically, as merely the reflexive behavioural component of a strict homeostatic regulatory system. Hunger is seen to arise in response to energy deficit; meal size is determined by the passage of nutrients into the gut and the stimulation of multiple satiety signals; and overall energy intake is modified to reflect the balance of fuel reserves and energy expenditure. But everyday experience shows that we rarely eat simply through need. Rather, food stimuli exert a powerful influence over consumption through their appeal to innate and learned appetites, generating the psychological experiences of hunger, craving and delight independently of energy status. That these important and influential subjective experiences are mediated through complex neurochemical processes is self-evident; but the chemical nature of our infatuation with, and subservience to, the motivating properties of foods are overshadowed by mechanistic, peripherally anchored models that take little account of psychological factors, and which consequently struggle to explain the phenomenon of obesity. This chapter discusses recent developments that suggest the endocannabinoids are key components of the central mechanisms that give rise to the emotional and motivational experiences that lead us to eat and to overconsume.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abel EL (1971) Effects of marijuana on the solution of anagrams, memory and appetite. Nature 231:260–261
Acosta MC, Manubay J, Levin FR (2008) Pediatric obesity: parallels with addiction and treatment recommendations. Harv Rev Psychiatry. 16:80–96
Arnone M, Maruani J, Chaperon F et al. (1997) Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berlin) 132:104–106
Avraham Y, Ben Menachem A, Okun A et al. (2005) Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice. Brain Res Bull 65:117–123
Beck B (2007) Hypothalamic neuropeptides and feeding regulation. In: Kirkham TC, Cooper SJ (eds) Appetite and body weight: integrative systems and the development of anti-obesity drugs. Academic Press, Burlington, MA
Berridge KC (2000) Measuring hedonic impact in animals and infants: microstructure of affective taste reactivity patterns. Neurosci Biobehav Rev 24:173–198
Berridge KC (2007) Brain reward systems for food incentives hedonics in normal appetite and eating disorders. In: Kirkham TC, Cooper SJ (eds) Appetite and body weight: integrative systems and the development of anti-obesity drugs. Academic Press, Burlington, MA
Blundell JE, Jebb SA, Stubbs RJ et al. (2006) Effect of rimonabant on energy intake, motivation to eat and body weight with or without hypocaloric diet: the REBA study. International Congress on Obesity, Sydney, Australia (poster)
Bodnar RJ (2004) Endogenous opioids and feeding behavior: a 30-year historical perspective. Peptides 25:697–725
Cannon WB (1932) The wisdom of the body. WW Norton & Company, New York
Cani PD, Montoya ML, Neyrinck AM, Delzenne NM, Lambert DM (2004) Potential modulation of plasma ghrelin and glucagon-like peptide-l by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide. Br J Nutr 92:757–761
Chee MJ, Colmers WF (2008) Y eat? Nutrition 24:869–877
Chen R, Huang R, Shen C et al. (2004) Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice. Brain Res Brain Res Rev 999:227–230
Colombo G, Agabio R, Diaz G et al. (1998) Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci 63:PL113–PL117
Cooper SJ, Kirkham TC (1993) Opioid mechanisms in the control of food consumption and taste preferences. In: Herz A, Akil H, Simon EJ (eds) Handbook of experimental pharmacology, vol. 104, part II. Springer, Berlin
Cota D, Marsicano G, Tschop M et al. (2003) The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112:423–431
Di Marzo V, Matias I (2005) Endocannabinoid control of food intake and energy balance. Nature Neurosci 8:585–589
Di Marzo V, Goparaju SK, Wang L et al. (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410:822–825
Drewnowski A, Krahn DD, Demitrack MA et al. (1992) Taste responses and preferences for sweet high-fat foods: evidence for opioid involvement. Physiol Behav 51:371–379
Figlewicz Latteman D, Sanders NM, MacDonald A et al. (2007) Integration of peripheral adiposity signals and psychological controls of appetite. In: Kirkham TC, Cooper SJ (eds) Appetite and body weight: integrative systems and the development of anti-obesity drugs. Academic Press, Burlington, MA
Freedland CS, Poston JS, Porrino LJ (2000) Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding. Pharmacol Biochem Behav 67:265–270
Gallate J, McGregor I (1999) The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716. Psychopharmacology 142:302–308
Gallate J, Saharov T, Mallet P et al. (1999) Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. Eur J Pharmacol 370:233–240
Gaoni Y, Mechoulam R (1971) The isolation and structure of delta-1-tetrahydrocannabinol and other neutral cannabinoids from hashish. J Am Chem Soc 93:217–224
Gardner E, Vorel S (1998) Cannabinoid transmission and reward-related events. Neurobiol Disease 5:502–533
Gibson EL, Brunstrom JM (2007) Learned influences on appetite, food choice, and intake: evidence in human beings. In: Kirkham TC, Cooper SJ (eds) Appetite and body weight: integrative systems and the development of anti-obesity drugs. Academic Press, Burlington, MA
Gomez R, Navarro M et al. (2002) A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci 22:9612–9617
Hao S, Avraham Y, Mechoulam R et al. (2000) Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. Eur J Pharmacol 392:147–156
Harrold J, Elliott C, King P et al. (2002) Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food? Brain Res 952:232–238
Higgs S, Williams CM, Kirkham TC (2003) Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716. Psychopharmacology (Berl) 165:370–377
Hildebrandt AL, Kelly-Sullivan DM, Black SC (2003) Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice. Eur J Pharmacol 462:125–132
Jamshidi N, Taylor D (2001) Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br J Pharmacol 134:1151–1154
Jarrett MM, Limebeer CL, Parker LA (2005) Effect of delta9-tetrahydrocannabinol on sucrose palatability as measured by the taste reactivity test. Physiol Behav 86:475–479
Jarrett MM, Scantlebury J, Parker LA (2007) Effect of delta(9)-tetrahydrocannabinol on quinine palatability and AM251 on sucrose and quinine palatability using the taste reactivity test. Physiol Behav 90:425–430
Kalra SP (2008) Central leptin insufficiency syndrome: an interactive etiology for obesity, metabolic and neural diseases and for designing new therapeutic interventions. Peptides 29:127–138
Kirkham TC (1990) Enhanced anorectic potency of naloxone in rats sham feeding 30% sucrose: reversal by repeated naloxone administration. Physiol Behav 47:419–426
Kirkham TC (1990b) Enhanced anorectic potency of naloxone in rats sham feeding 30% sucrose: reversal by repeated naloxone administration. Physiol Behav 47:419–426
Kirkham TC (2005) Endocannabinoids in the regulation of appetite and body weight. Behav Pharmacol 16:297–313
Kirkham TC, Cooper SJ (1988) Naloxone attenuation of sham feeding is modified by manipulation of sucrose concentration. Physiol Behav 44:491–494
Kirkham TC, Williams CM (2001a) Endogenous cannabinoids and appetite. Nutr Res Rev 14:65–86
Kirkham TC, Williams CM (2001b) Endocannabinoids: neuromodulators of food craving? In: Hetherington M (ed) Food cravings and addiction. Leatherhead Publishing, Leatherhead, UK
Kirkham TC, Williams CM (2001c) Synergistic effects of opioid and cannabinoid antagonists on food intake. Psychopharmacology (Berl) 153:267–270
Kirkham TC, Williams CM, Fezza F et al. (2002) Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 136:550–557
Koch JE, Matthews SM (2001) Delta9-tetrahydrocannabinol stimulates palatable food intake in Lewis rats: effects of peripheral and central administration. Nutr Neurosci 4:179–187
Kola B, Farkas I, Christ-Crain M et al. (2008) The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLoS ONE 3:e1797
Konturek PC, Konturek JW, Czesnikiewicz-Guzik et al. (2005) Neuro-hormonal control food intake; basic mechanisms and clinical implications. J Physiol Pharmacol 56(Suppl 6):5–25
Leventhal L, Kirkham TC, Cole JL et al. (1995) Selective actions of central mu and kappa opioid antagonists upon sucrose intake in sham-fed rats. Brain Res 685:205–210
Levitsky DA (2002) Putting behavior back into feeding behavior: a tribute to George Collier. Appetite 38:143–148
Levitsky DA (2005) The non-regulation of food intake in humans: Hope for reversing the epidemic. 86:623–632
Lowe MR, Butryn ML (2007) Hedonic hunger: a new dimension of appetite? Physiol Behav 91:432–439
Mahler SV, Smith KS, Berridge KC (2007) Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances ‘liking’ of a sweet reward. Neuropsychopharmacology 32:2267–2278
Maljaars J, Peters HP, Masclee AM (2007) The gastrointestinal tract: neuroendocrine regulation of satiety and food intake. Aliment Pharmacol Ther 26(Suppl 2):241–250
Marín Bivens CL, Thomas WJ, Stanley BG (1998) Similar feeding patterns are induced by perifornical neuropeptide Y injection and by food deprivation. Brain Res 782:271–280
Matias I, Cristino L, di Marzo V (2008) Endocannabinoids: some like it fat (and sweet too). J Neuroendocrinol 20(Suppl 1):100–109
Melis T, Succu S, Sanna F et al. (2007) The cannabinoid antagonist SR 141716A (Rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food. Neurosci Lett 419:231–235
Meschler JP, Howlett AC (2001) Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and a monkey striatum. Neuropharmacology 14:918–926
Miller CC, Murray TF, Freeman KG et al. (2004) Cannabinoid agonist, CP 55, 940, facilitates intake of palatable foods when injected into the hindbrain. Physiol Behav 80:611–616
Osei-Hyiamen D, DePetrillo M, Pacher P et al. (2005) Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 115:1298–1305
Pecina S, Berridge KC (2000) Opioid site in nucleus accumbens shell mediates eating and hedonic ‘liking’ for food: map based on microinjection Fos plumes. Brain Res 863:71–86
Pério A, Barnouin MC, Poncelet M et al. (2001) Activity of SR141716 on post-reinforcement pauses in operant responding for sucrose reward in rats. Behav Pharmacol 12:641–645
Pertwee RG (2008) Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. Addict Biol 13(2):147–159
Pickel VM, Chan J, Kash TL et al. (2004) Compartment-specific localization of cannabinoid (CB1) and mu-opioid receptors in rat nucleus accumbens. Neuroscience 127:101–112
Pickel VM, Chan J, Kearn et al. (2006) Targeting dopamine D2 and cannabinoid-1 (CB-1) in rat nucleus accumbens. J Comp Neurol 495:299–313
Poncelet M, Maruani J, Calassi R et al. (2003) Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice. Neurosci Lett 343:216–218
Ravinet Trillou C, Arnone M, Delgorge C et al. (2003) Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am J Physiol Regul Integr Comp Physiol 284:R345–R353
Riegel AC, Lupica CR (2004) Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area. J Neurosci 24:11070–11078
Rinaldi-Carmona M, Barth F, Congy C et al. (2004) SR147778 [5-(4-Bromophenyl)-1–1(2, 4-dichlorophenyl)-4-ethyl -N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacolo- gical characterization. J Pharmacol Exp Ther 310:905–914
Rolls BJ (1986) Sensory-specific satiety. Nutr Rev 44:93–101
Rutkowska M (2004) The effect of AM251, a cannabinoid CB1 receptor antagonist, on food intake in rats. Acta Pol Pharm 61:401–403
Sanchis-Segura C, Cline B, Marsicano G et al. (2004) Reduced sensitivity to reward in CB1 knockout mice. Psychopharmacology (Berl) 176:223–232
Scarpaci PJ, Zhang Y (2007) Elevated leptin: consequence or cause of obesity? Front Biosci 12:3531–3544
Shearman L, Rosko K, Fleischer R et al. (2003) Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice. Behav Pharmacol 14:573–582
Simiand J, Keane M, Keane P et al. (1998) SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav Pharmacol 9:179–181
Solinas M, Goldberg SR (2005) Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems. Neuropsychopharmacology 30:2035–2045
Solinas M, Justinova Z, Goldberg SR et al. (2006) Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nuclear accumbens shell in rats. J. Neurochem 98:408–419
Solinas M, Goldberg SR, Piomelli D (2008) The endocannabinoid system in brain reward processes. Br J Pharmacol 154:369–383
Solinas M, Zangen A, Thiriet N, Goldberg SR (2004) β-endorphin elevations in the ventral tegmental area regulate the discriminative effects of Δ9-tetrahydrocannabinol. Eur J Neurosci 19:3183–3192
Soria-Gomez E, Matias I et al. (2007) Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus. Br J Pharmacol 151:1109–1116
Speakman JR (2007) Gene environment interactions and the origin of the modern obesity epidemic: a novel “nonadaptive drift” scenario. In: Kirkham TC, Cooper SJ (eds) Appetite and body weight: integrative systems and the development of anti-obesity drugs. Academic Press, Burlington, MA
Stratford TR (2007) The nucleus accumbens shell as a model of integrative subcortical forebrain systems regulating food intake. In: Kirkham TC, Cooper SJ (eds) Appetite and body weight: integrative systems and the development of anti-obesity drugs. Academic Press, Burlington, MA
Sullivan RJ, Hagen EH, Hammerstein P (2008) Revealing the paradox of drug reward in human evolution. Proc Biol Sci 275:1231–1241
Tallett AJ, Blundell JE et al. (2007a) Grooming, scratching and feeding: role of response competition in acute anorectic response to rimonabant in male rats. Psychopharmacology (Berl) 195:27–39
Tallett AJ, Blundell JE et al. (2007b) Acute anorectic response to cannabinoid CB1 receptor antagonist/inverse agonist AM 251 in rats: indirect behavioural mediation. Behav Pharmacol 18:591–600
Tart C (1970) Marijuana intoxication: common experiences. Nature 226:701–704
Tucci SA, Rogers EK, Korbonits M, Kirkham TC (2004) The cannabinoid CBI receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin. Br J Pharmacol 143:520–523
Valassi E, Scacchi M, Cavagnini F (2008) Neuroendocrine control of food intake. Nutr Metab Cardiovascular Dis 18:158–168
Valenti M, Viganòb D, Cascioa MG et al. (2004) Differential diurnal variations of anandamide and 2 arachidonoyl-glycerol levels in rat brain. Cell Mol Life Sci 61:945–950
van der Stelt M, Di Marzo V (2003) The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders. Eur J Pharmacol 480:133–150
Verty A, McGregor I, Mallet P (2004a) The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Delta9-tetrahydrocannabinol. Brain Res 1020:188–195
Verty AN, McGregor IS, Mallet PE (2004b) Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats. Neurosci Lett 354:217–220
Vickers S, Webster L, Wyatt A et al. (2003) Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats. Psychopharmacology (Berl) 167:103–111
Werner N, Koch J (2003) Effects of the cannabinoid antagonists AM281 and AM630 on deprivation-induced intake in Lewis rats. Brain Res 967:290–292
Wiley JL, Burston JJ, Leggett DC et al. (2005) CB(1) cannabinoid receptor-mediated modulation of food intake in mice. Br J Pharmacol 145:293–300
Williams CM, Kirkham TC (1999) Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology (Berl) 143:315–317
Williams CM, Kirkham TC (2002a) Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol Biochem Behav 71:333–340
Williams CM, Kirkham TC (2002b) Observational analysis of feeding induced by Delta9-THC and anandamide. Physiol Behav 76:241–250
Williams CM, Rogers PJ, Kirkham TC (1998) Hyperphagia in pre-fed rats following oral delta9 THC. Physiol Behav 65:343–346
Williams CM, Rogers PJ, Kirkham TC (1998b) Hyperphagia in pre-fed rats following oral delta9-THC. Physiol Behav 65:343–346
Woods SC, Ramsay DS (2007) Homeostasis: beyond Curt Richter. Appetite 49(2):388–398
Wren AM, Bloom SR (2007) Gut hormones and appetite control. Gastroenterology 132:2116–2130
Yeomans MR (2007) The role of palatability in control of human appetite: implications for understanding and treating obesity. In: Kirkham TC, Cooper SJ (eds) Appetite and body weight: integrative systems and the development of anti-obesity drugs. Academic Press, Burlington, MA
Yeomans MR, Gray RW (1996) Selective effects of naltrexone on food pleasantness and intake. Physiol Behav 60:439–446
Zhou D, Shearman L (2004) Voluntary exercise augments acute effects of CB1-receptor inverse agonist on body weight loss in obese and lean mice. Pharmacol Biochem Behav 77:117–125
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kirkham, T.C. (2009). Endocannabinoids and the Non-Homeostatic Control of Appetite. In: Kendall, D., Alexander, S. (eds) Behavioral Neurobiology of the Endocannabinoid System. Current Topics in Behavioral Neurosciences, vol 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-88955-7_9
Download citation
DOI: https://doi.org/10.1007/978-3-540-88955-7_9
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-88954-0
Online ISBN: 978-3-540-88955-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)